Cooper Companies Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Cooper Companies will report Q3 earnings Sept. 9; analysts expect EPS of $1.12 and revenue of $1.10B.
News
Current market catalysts
Source-attributed headlines with timestamps and links to the companies and crypto markets they mention.
Latest Coverage
Latest Headlines
30 headlines
CGI Acquires Callibrity; Terms Undisclosed
CGI (TSX:GIB) (NYSE:GIB), one of the world's largest independent technology and professional services firms, today announced the acquisition of Callibrity, strengthening CGI's presence in Cincinnati and
BMO Capital Initiates Coverage On Deckers Outdoor with Underperform Rating, Announces Price Target of $70
BMO Capital analyst Kelly Crago initiates coverage on Deckers Outdoor (NYSE:DECK) with a Underperform rating and announces Price Target of $70.
Albertsons Companies Appoints Meg Whitman As Executive Chair Of The Company’s Board Of Directors
Kim Fennebresque named Lead Independent DirectorWhitman brings over 40 years of business, technology and strategic innovation experience to Albertsons Cos. as the retailer embarks on a defining period in its
8-K filing — Avalanche Treasury Corp (AVAT)
Filed: 2026-09-09 AccNo: 0001104659-26-106101 Size: 278 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
MannKind And Rose Pharma Enter Into Worldwide Licensing And Collaboration Agreement To Develop ROSE-010 Technosphere For Weight Management
Collaboration combines Rose Pharma investigational rapid-acting GLP-1 receptor agonist with MannKind’s Technosphere® inhalation technologyMannKind to receive an equity interest and potential royalties while providing
HC Wainwright & Co. Reiterates Neutral on Evommuneto Neutral
HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Evommune (NYSE:EVMN) from Neutral to Neutral.
8-K filing — Albertsons Companies, Inc. (ACI)
Filed: 2026-09-09 AccNo: 0001646972-26-000054 Size: 163 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
8-K filing — Chemours Co (CC)
Filed: 2026-09-09 AccNo: 0001627223-26-000027 Size: 21 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Panama-Flagged Tanker 'New Andros' With Cargo Of 2M Barrels Of Iraqi Fuel Oil Struck By Drone In Iraqi Territorial Waters; Iraqi Rescue Boats Extinguished Fire, No Reports Of Casualties
– Reuters cites Iraqi port officials
Needham Initiates Coverage On Kodiak AI with Buy Rating, Announces Price Target of $8
Needham analyst Chris Pierce initiates coverage on Kodiak AI (NASDAQ:KDK) with a Buy rating and announces Price Target of $8.
Iranian Foreign Ministry Condemns U.S. Attacks On Iranian Tankers; Says Its Armed Forces Acted In Self-Defence Against 'American Tankers' And U.S. Bases In Jordan
– Reuters cites Iran Foreign Ministry statement
Needham Reiterates Buy on ServiceTitan, Maintains $100 Price Target
Needham analyst Scott Berg reiterates ServiceTitan (NASDAQ:TTAN) with a Buy and maintains $100 price target.
Top 3 Materials Stocks That Could Blast Off In September
Scotts Miracle-Gro, Linde and Graphic Packaging are oversold materials stocks with RSI near 30, potentially offering undervalued buying opportunities.
SpaceX Doesn’t Need to Beat Verizon, AT&T or T-Mobile to Disrupt Wireless, Analyst Says
SpaceX (SPCX) shares drop premarket amid a broader market slide. Get the latest analyst outlook, stock targets, and market updates.
Translational Development Acquisition Merger Partner ProLogium Receives Investment From Kyushu Electric Power
ProLogium today announced a further deepening of its long-term strategic partnership with Kyushu Electric Power Co., Inc. (Kyushu Electric Power). Following ongoing collaboration across energy, next-generation batteries
BTIG Reiterates Buy on ServiceTitan, Maintains $110 Price Target
BTIG analyst Nick Altmann reiterates ServiceTitan (NASDAQ:TTAN) with a Buy and maintains $110 price target.
JinkoSolar To Change Name to Jinko Holdings Limited; To Focus On AI, Renewable Energy, Advanced Materials, Commercial Space And Other Frontier Technologies
JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE:JKS), today announced that its board of directors (the "Board") has approved a proposal to change the Company's English name
BTIG Reiterates Buy on Neuronetics, Maintains $6 Price Target
BTIG analyst Sam Eiber reiterates Neuronetics (NASDAQ:STIM) with a Buy and maintains $6 price target.
KBR's Pre-Spinoff Unit Trinzic Awarded Three-Year U.S. Government Contract To Continue Advancing Mission-Critical Radio Frequency Engineering And Modernization
The award supports the continuity and readiness of essential national security systems. It reinforces KBR’s strategic position as a trusted technology partner, combining deep mission expertise with an outcome-driven
BTIG Reiterates Buy on Nektar Therapeutics, Maintains $178 Price Target
BTIG analyst Julian Harrison reiterates Nektar Therapeutics (NASDAQ:NKTR) with a Buy and maintains $178 price target.
IDEAYA Biosciences Announced First Patient Has Been Dosed In The OptimUM-11 Phase 3 Registrational Trial Evaluating Darovasertib In Combination With Crizotinib For Patients With Primary Uveal Melanoma
Global Phase 3 registrational trial evaluating darovasertib, a first-in-class oral protein kinase C (PKC) inhibitor, in combination with crizotinib, an oral cMET inhibitor, as adjuvant therapy for patients with primary
AEVEX Receives $20.5M In New U.S. Government Awards For One‑Way Attack System Capabilities
These awards expand AEVEX’s support for operational requirements across high‑priority mission areas. Under these efforts, AEVEX will deliver one‑way attack systems and provide associated engineering, development, and
BTIG Reiterates Buy on Braze, Maintains $35 Price Target
BTIG analyst Nick Altmann reiterates Braze (NASDAQ:BRZE) with a Buy and maintains $35 price target.
Titan Mining Discloses Permitting Progress Across Federal And State Programs For The Kilbourne Graphite Project In New York; Remains On Track To Begin Production in 2028
FEDERAL PERMITTINGKilbourne remains on track under the FAST-41 permitting schedule, with all federal permits targeted for issuance by no later than August 2027.Section 404 (Clean Water Act): U.S. Army Corps of Engineers
HC Wainwright & Co. Reiterates Buy on PepGen, Maintains $20 Price Target
HC Wainwright & Co. analyst Ananda Ghosh reiterates PepGen (NASDAQ:PEPG) with a Buy and maintains $20 price target.
HC Wainwright & Co. Initiates Coverage On TriSalus Life Sciences with Buy Rating, Announces Price Target of $11
HC Wainwright & Co. analyst Swayampakula Ramakanth initiates coverage on TriSalus Life Sciences (NASDAQ:TLSI) with a Buy rating and announces Price Target of $11.
Anthropic Researcher Puts Odds of AI Wiping Out Humanity Within a Decade Above 10%: 'We Do Not Yet Have a Plan'
Anthropic researcher Evan Hubinger warned that AI could pose a significant risk to humanity within the next decade.
8-K filing — SYSCO CORP (SYY)
Filed: 2026-09-09 AccNo: 0000950142-26-002525 Size: 267 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Revvity To Acquire French Biotech Firm Human Cell Design To Gain Exposure To Human Cell Models And Preclinical Research Solutions For Diabetes, Obesity And Other Metabolic Diseases
The acquisition is expected to add HCD’s human pancreatic beta cell models to Revvity’s Life Sciences portfolio, supporting drug discovery, screening and preclinical research, including applications in GLP-1 and other
- Source
- Source-attributed market-news archive
- Observed
- Checked
- Cadence
- Continuous captured-news feed
- Status
- fresh